Full Press Release Details
Bacterin To Present at the Singular Research
9th Annual Best of the Uncovereds Conference
BELGRADE, MT, November 17, 2014 -- Bacterin
International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical
applications, today announced that its CFO, John Gandolfo, will present at the Singular Research 9th Annual Best of the Uncovereds
Conference, to be held November 20, 2014 at the Westin in New York at Times Square. Bacterin's presentation will take place Thursday,
November 20, 2014 at 10:30am ET.
Institutional investors that wish to request
a meeting with Bacterin should contact Singular Research or The Cockrell Group at 877.889.1972.
A live broadcast of the conference presentation
will be available. To access the broadcast, go to the "Investor Info" section of the Company's website at www.bacterin.com.
A replay of the conference presentation will also be available.
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE
MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. These products are used
in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot
and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division
develops, employs, and licenses coatings for various medical device applications. For further information, please visit www.bacterin.com.
Important Cautions Regarding Forward-looking
The presentation may contain forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant risks and
uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future
events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates,"
"intends," "plans," "believes," "estimates," "projects," "forecasts,"
"strategy," "will," "goal," "target," "prospects," "potential," "optimistic,"
"confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical
fact also may be deemed to be forward- looking statements. We caution that these statements by their nature involve risks and uncertainties,
and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability
to meet its existing and anticipated contractual obligations, including financial covenant and other obligations contained in the
Company's secured lending facility; the Company's ability to manage cash flow and achieve profitability; the Company's ability
to remain listed on the NYSE MKT; the Company's ability to develop, market, sell and distribute desirable applications, products
and services and to protect its intellectual property; the ability of the Company's sales force to achieve expected results; the
ability of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as and
when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees
with appropriate skills and expertise; the Company's ability to successfully conclude government investigations; the impact of
changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors;
and other factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form
10-Q under the heading "Risk Factors." The Company undertakes no obligation to release publicly any revisions to any
forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated
events, except as required by law.